Median Technologies inks dev deal with Medidata for cloud-based imaging tech

Median Technologies (EPA:ALMDT) and Medidata said today they inked a collaborative deal looking to leverage their capabilities to streamline the growth and use of medical imaging in cancer clinical trials. Through the deal, Median Technologies will use Medidata's Clinical Cloud to accelerate oncology medicine development, the companies said. Median will also use Medidata's Medical Imaging system to transition its existing legacy imaging study management systems to a single digital environment, the companies said. "Our collaboration with Medidata will not only ease the management of images during clinical drug trials—it will enhance our analytical rigor, enabling our teams to extract high-quality imaging biomarkers for better study and patient outcomes. Medidata's ima...

from ! Medicine by Alexandros G. Sfakianakis via alwin on Inoreader http://ift.tt/2tAe7zW
via IFTTT